0001554199-14-000004.txt : 20140821
0001554199-14-000004.hdr.sgml : 20140821
20140821155329
ACCESSION NUMBER: 0001554199-14-000004
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20140821
DATE AS OF CHANGE: 20140821
EFFECTIVENESS DATE: 20140821
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mycell Technologies LLC
CENTRAL INDEX KEY: 0001554199
IRS NUMBER: 010939011
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1212
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-218646
FILM NUMBER: 141057597
BUSINESS ADDRESS:
STREET 1: 140 EAST RIDGEWOOD AVENUE
STREET 2: SUITE 125
CITY: PARAMUS
STATE: NJ
ZIP: 07652
BUSINESS PHONE: 201-483-9102
MAIL ADDRESS:
STREET 1: 140 EAST RIDGEWOOD AVENUE
STREET 2: SUITE 125
CITY: PARAMUS
STATE: NJ
ZIP: 07652
FORMER COMPANY:
FORMER CONFORMED NAME: MyCell Technologies LLC
DATE OF NAME CHANGE: 20120713
D/A
1
primary_doc.xml
X0707
D/A
LIVE
0001554199
Mycell Technologies LLC
140 EAST RIDGEWOOD AVENUE
SUITE 125
PARAMUS
NJ
NEW JERSEY
07652
201-483-9102
DELAWARE
MyCell Technologies LLC
Limited Liability Company
true
2009
Benjamin
Mamola
140 EAST RIDGEWOOD AVENUE
SUITE 125
PARAMUS
NJ
NEW JERSEY
07652
Promoter
Volker
Berl
140 EAST RIDGEWOOD AVENUE
SUITE 125
PARAMUS
NJ
NEW JERSEY
07652
Executive Officer
Director
Promoter
Bruce
Lipshutz
140 EAST RIDGEWOOD AVENUE
SUITE 125
PARAMUS
NJ
NEW JERSEY
07652
Promoter
Frank
A.
Gallagi
140 EAST RIDGEWOOD AVENUE
SUITE 125
Paramus
NJ
NEW JERSEY
07652
Executive Officer
Joseph
C.
Krasinski
140 EAST RIDGEWOOD AVENUE
SUITE 125
Paramus
NJ
NEW JERSEY
07652
Executive Officer
Reno
Deldotto
140 EAST RIDGEWOOD AVENUE
SUITE 125
Paramus
NJ
NEW JERSEY
07652
Director
Richard
Peterson
140 EAST RIDGEWOOD AVENUE
SUITE 125
Paramus
NJ
NEW JERSEY
07652
Director
Mark
Shefts
140 EAST RIDGEWOOD AVENUE
SUITE 125
Paramus
NJ
NEW JERSEY
07652
Director
Tony
Pollante
140 EAST RIDGEWOOD AVENUE
SUITE 125
Paramus
NJ
NEW JERSEY
07652
Director
Other Technology
Decline to Disclose
- 06b
true
0001554199-14-000003
2014-05-23
false
true
false
5000
4500000
3596301
903699
Consists of cash in the amount of $2,480,000 and conversion of promissory notes in the principal amount of $1,116,301, for an aggregate of $3,596,301.
false
4
0
0
660000
true
Assumes the full proceeds are raised and expended over a one year period. Represents salaries and consulting fees payable to 4 executives and a consultant who is a founder.
false
Mycell Technologies LLC
s/Frank Gallagi/
Frank Gallagi
Chief Financial Officer
2014-08-21